Shenzhen Salubris Pharmaceuticals Co Ltd

002294

Company Profile

  • Business description

    Shenzhen Salubris Pharmaceuticals Co Ltd is a pharmaceutical company dedicated to the research, development, and sale of medical products for cardiovascular diseases, cephalosporins, and bone resorption inhibitors. Its products mainly focus on the areas of cardio-cerebral vascular disease, diabetes, complications, anti-tumor, and orthopedics. Its business lines include high-end chemical drugs, biological drugs, and medical devices. Its businesses are located in China, the United States, Germany, France, and Japan, and other countries and regions.

  • Contact

    No. 6009, Shennan Avenue
    37th Floor, Main Building, Tower B
    Chegongmiao Greenview Plaza
    Futian District
    Shenzhen518040
    CHN

    T: +86 75583867888

    https://www.salubris.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 December 2025

    Employees

    3,596

Stocks News & Analysis

stocks

ChatGPT enters the retail space and one company surges

Investors cheer the ability to purchase directly from ChatGPT.
stocks

Alibaba fair value increases by 49%

Stronger-than-expected AI demand internationally and domestically.
stocks

Our fair value on ASX share falls by half

Downgrading our estimates due to lower growth.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,157.001.600.02%
CAC 407,880.8710.190.13%
DAX 4023,745.065.590.02%
Dow JONES (US)46,316.0768.780.15%
FTSE 1009,299.8415.010.16%
HKSE26,766.65143.770.54%
NASDAQ22,591.15107.090.48%
Nikkei 22544,967.3976.36-0.17%
NZX 50 Index13,169.4436.880.28%
S&P 5006,661.2117.510.26%
S&P/ASX 2008,872.102.800.03%
SSE Composite Index3,874.0011.460.30%

Market Movers